tradingkey.logo
tradingkey.logo
Search

LENZ Therapeutics Inc

LENZ
Add to Watchlist
3.715USD
-0.045-1.20%
Market hours 09/24, 13:52(ET)
116.47MMarket Cap
LossP/E TTM

LENZ Financials

See LENZ Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
116.47M
Dividend TTM
0.00
P/E TTM
-1.02
EPS TTM
-3.64
Revenue
19.09M
Net Profit
-49.77M
ROE
-49.71%
ROA
-46.01%

LENZ Therapeutics Inc Earnings Date

Latest Release
Aug 11, 2026
EPS / Forecast
-1.02/-1.07
Revenue / Forecast
5.49M/2.37M

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
-91.56%-1.02
-149.16%-1.32
-151.26%-1.15
-55.65%-0.59
-32.63%-0.53
84.95%-0.53
83.44%-0.46
86.32%-0.38
94.13%-0.40
-17.67%-3.53
10.21%-2.77
---2.75
---6.82
---3.00
---3.09
---9.80
----
----
----
----
Revenue
9.72%5.49M
--1.90M
--1.59M
--12.50M
--5.00M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Net Profit
-114.04%-31.92M
-183.80%-41.49M
-183.72%-35.90M
-63.49%-16.70M
-45.43%-14.91M
12.19%-14.62M
44.79%-12.65M
54.57%-10.21M
81.46%-10.25M
30.44%-16.65M
6.83%-22.92M
8.90%-22.48M
-113.27%-55.31M
7.36%-23.93M
-29.95%-24.60M
-69.15%-24.68M
-47.96%-25.94M
-31.08%-25.84M
---18.93M
-331.21%-14.59M
Net Margin
-95.08%-581.81%
---2182.43%
---2260.45%
---133.60%
---298.24%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Gross Margin
-5.10%94.90%
--43.40%
--73.68%
--100.00%
--100.00%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Revenue
9.72%5.49M
--1.90M
--1.59M
--12.50M
--5.00M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Operating profit
-102.72%-34.17M
-160.68%-44.13M
-152.63%-38.46M
-45.90%-18.89M
-17.45%-16.86M
-5.24%-16.93M
-4.27%-15.22M
5.36%-12.95M
31.54%-14.35M
32.59%-16.09M
45.42%-14.60M
47.70%-13.68M
21.71%-20.96M
8.06%-23.87M
-41.24%-26.75M
-79.11%-26.15M
-52.72%-26.78M
-177.09%-25.96M
---18.94M
-287.94%-14.60M
Net Profit
-114.04%-31.92M
-183.80%-41.49M
-183.72%-35.90M
-63.49%-16.70M
-45.43%-14.91M
12.19%-14.62M
44.79%-12.65M
54.57%-10.21M
81.46%-10.25M
30.44%-16.65M
6.83%-22.92M
8.90%-22.48M
-113.27%-55.31M
7.36%-23.93M
-29.95%-24.60M
-69.15%-24.68M
-47.96%-25.94M
-31.08%-25.84M
---18.93M
-331.21%-14.59M
Current assets
9.21%233.28M
35.64%268.37M
42.23%301.41M
-6.21%207.00M
7.15%213.60M
-8.68%197.86M
12.71%211.92M
-7.57%220.70M
-20.63%199.35M
-19.84%216.67M
-31.72%188.02M
-20.00%238.78M
-23.11%251.17M
-21.37%270.31M
-27.87%275.37M
-25.61%298.49M
-15.10%326.64M
90.69%343.76M
--381.74M
--401.23M
Total current liabilities
65.53%17.21M
201.16%25.81M
103.60%21.19M
111.62%16.32M
21.15%10.40M
-54.63%8.57M
116.93%10.41M
-38.50%7.71M
-30.05%8.58M
31.71%18.89M
-63.22%4.80M
-7.30%12.54M
1.67%12.27M
12.35%14.34M
7.41%13.04M
19.98%13.52M
53.58%12.07M
99.67%12.77M
--12.14M
--11.27M
Total assets
8.86%236.60M
35.42%272.54M
42.07%305.88M
-5.94%210.70M
7.25%217.33M
-7.39%201.25M
14.25%215.30M
-15.86%224.01M
-29.40%202.64M
-29.90%217.32M
-41.46%188.46M
-20.49%266.23M
-18.87%287.04M
-18.12%310.00M
-19.92%321.90M
-19.54%334.85M
-8.61%353.79M
106.99%378.61M
--401.99M
--416.15M
Total liabilities
58.06%17.33M
181.79%26.04M
91.95%21.54M
92.24%16.78M
12.86%10.97M
-51.75%9.24M
130.20%11.22M
-85.97%8.73M
-84.55%9.72M
-43.28%19.15M
-80.97%4.87M
238.24%62.21M
310.29%62.90M
95.13%33.77M
42.78%25.61M
14.81%18.39M
93.51%15.33M
168.03%17.31M
--17.94M
--16.02M
Total equity
6.25%219.26M
28.37%246.49M
39.32%284.34M
-9.92%193.93M
6.97%206.37M
-3.11%192.01M
11.17%204.08M
5.52%215.28M
-13.93%192.92M
-28.26%198.17M
-38.04%183.58M
-35.53%204.02M
-33.77%224.15M
-23.55%276.22M
-22.85%296.29M
-20.91%316.45M
-10.74%338.46M
104.75%361.30M
--384.05M
--400.13M
Net operating income
-236.40%-38.71M
-109.25%-33.58M
-263.79%-33.02M
18.84%-8.59M
27.14%-11.51M
32.95%-16.05M
80.21%-9.08M
-12.55%-10.58M
-15.67%-15.79M
-13.59%-23.94M
-104.54%-45.88M
57.69%-9.40M
38.20%-13.65M
0.78%-21.07M
-43.84%-22.43M
-44.13%-22.22M
-60.29%-22.09M
-163.52%-21.24M
-195.83%-15.59M
-518.33%-15.41M
Net investment
9219.32%37.75M
75.56%33.16M
-657.06%-89.81M
93.04%-4.33M
99.58%-414.00K
4.94%18.89M
-125.20%-11.86M
-197.42%-62.23M
-236.23%-98.39M
-58.30%18.00M
248.14%47.08M
1727.09%63.88M
181.87%72.23M
125.29%43.16M
1478.59%13.52M
196.15%3.50M
-11461.86%-88.22M
-47307.22%-170.67M
-60.29%-981.00K
-556.32%-3.64M
Net financing
-98.51%395.00K
-68.18%14.00K
231249.06%122.61M
-97.99%598.00K
1339.49%26.49M
-99.97%44.00K
-19.70%53.00K
372625.00%29.82M
-1823.39%-2.14M
2140950.00%171.27M
-72.95%66.00K
113.56%8.00K
-69.90%124.00K
---8.00K
-22.04%244.00K
-100.19%-59.00K
-99.81%412.00K
-100.00%0.00
-97.93%313.00K
76028.57%31.89M

FAQs

What is the total revenue of LENZ Therapeutics Inc?

According to LENZ Therapeutics Inc's FY2025 earnings report, its total revenue reached 19.09M, with a year-on-year change of 19.09M.

What are the current assets of LENZ Therapeutics Inc?

According to LENZ Therapeutics Inc's FY2025 earnings report, its current assets were 301.41M, with a year-on-year change of 42.23.

What are the total assets of LENZ Therapeutics Inc?

According to LENZ Therapeutics Inc's FY2025 earnings report, its total assets of LENZ Therapeutics Inc were 305.88M, with a year-on-year change of 42.07.

What are the total liabilities of LENZ Therapeutics Inc?

According to LENZ Therapeutics Inc's FY2025 earnings report, its total liabilities of LENZ Therapeutics Inc were 21.54M, with a year-on-year change of 91.95.

What is the total equity of LENZ Therapeutics Inc?

According to LENZ Therapeutics Inc's FY2025 earnings report, its total equity of LENZ Therapeutics Inc was 284.34M, with a year-on-year change of 39.32.

What is the net operating income of LENZ Therapeutics Inc?

According to LENZ Therapeutics Inc's FY2025 earnings report, its net operating income of LENZ Therapeutics Inc was -91.14M, with a year-on-year change of -55.50.

What is the net investment of LENZ Therapeutics Inc?

According to LENZ Therapeutics Inc's FY2025 earnings report, its net investment of LENZ Therapeutics Inc was -75.67M, with a year-on-year change of 51.02.

What is the net financing of LENZ Therapeutics Inc?

According to LENZ Therapeutics Inc's FY2025 earnings report, its net financing of LENZ Therapeutics Inc was 149.75M, with a year-on-year change of -24.75.

What is the Earnings Per Share (EPS) of LENZ Therapeutics Inc?

According to LENZ Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -2.85, with a year-on-year change of -21.88.

What is the net income of LENZ Therapeutics Inc?

According to LENZ Therapeutics Inc's FY2025 earnings report, its net income was -82.13M, with a year-on-year change of -65.02.

What is the Return on Equity (ROE) of LENZ Therapeutics Inc?

According to LENZ Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -33.63, with a year-on-year change of -30.98.

What is the Return on Assets (ROA) of LENZ Therapeutics Inc?

According to LENZ Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -31.52, with a year-on-year change of -27.84.

What is the operating profit of LENZ Therapeutics Inc?

According to LENZ Therapeutics Inc's FY2025 earnings report, its operating profit was -91.14M, with a year-on-year change of -55.50.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.